Medical News

RSS

Anti-cancer activity of HuCAL antibody revealed by new data from OncoMed

MorphoSys AG's (FSE: MOR; Prime Standard Segment, TecDAX) partner OncoMed Pharmaceuticals today announced that Proceedings of the National Academy of Sciences of the United States of America (PNAS) has published online data demonstrating the potent anti-cancer activity of OMP-18R5, a HuCAL antibody targeting the Wnt pathway, in multiple preclinical human tumor models. OMP-18R5 is currently in Phase 1 clinical testing.

5 Jul 2012

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

4 Jul 2012

Strawberry extracts actively stimulate proteins that offer protection against cardiovascular disease

Strawberries, the traditional summer treat associated with Wimbledon could be serving up some unexpected health benefits.

4 Jul 2012

New research approach can help predict the 'tenability' of antibiotics

Research by Wageningen University, part of Wageningen UR, has shown that the development of bacteria with resistance against the antibiotic cefotaxime occurs more often and more predictably than was previously assumed. Bacterial populations were found to have many mutations that increase resistance and therefore have a negative effect on public health.

4 Jul 2012

Geological Society of London, Elsevier win 2012 Getenergy award

Elsevier, a world-leading provider of scientific, medical and technical information products and services, today announced that, together with the Geological Society of London, it has won the award for best Education/Industry Partnership at the 2012 Getenergy awards ceremony.

4 Jul 2012

Vitrolife's EmbryoGlue medium increases implantation and pregnancy rates

In a study presented at the on-going ESHRE conference in Istanbul, Vitrolife's patent protected medium EmbryoGlue has once again been proven to increase both implantation and pregnancy rates, regardless of hormone stimulation of the endometrium or not.

4 Jul 2012

Madrid, Accenture implement HORUS system

Accenture and Madrid Health Service have fully implemented the Madrid Electronic Health Record (HORUS) system that captures all patient information into a single, integrated record for 26,000 clinicians to access across all parts of the regional healthcare system.

4 Jul 2012

Cashing in on the court's decision

Fundraisers for GOP presidential hopeful Mitt Romney as well as for the Democratic Congressional Campaign Committee report significant tallies in the days since the Supreme Court's health law decision.

4 Jul 2012

Italy's first successful pregnancy and delivery following transplantation of ovarian tissue

Although the first successful preservation of fertility from the freezing, thawing and grafting of ovarian tissue was reported eight years ago, the technique has remained experimental and confined to a few specialist centres. Now, with the announcement of a first pregnancy (and subsequent live birth) in Italy following the transplantation of ovarian tissue, there are indications that fertility preservation is moving into the mainstream of reproductive medicine and into a greater number of centres.

4 Jul 2012

Mississippi's lone abortion clinic gets reprieve

The state's only abortion clinic had been threatened with closure due to a state law requiring doctors to have hospital privileges.

4 Jul 2012

Pacific Prime Insurance Brokers announces expanded direct settlement network in Hong Kong

Pacific Prime Insurance Brokers Ltd. is pleased to announce an expanded direct settlement network in Hong Kong for Pacific Prime's customers holding an InterGlobal policy. Pacific Prime also negotiated an exclusive arrangement with InterGlobal in the Middle East to provide direct billing services for Dubai residents with an InterGlobal policy.

4 Jul 2012

New issue of 'Global Fund News Flash' available

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 5 of its newsletter, the "Global Fund News Flash."

4 Jul 2012

SET policy reduces risk of perinatal mortality in IVF and ICSI infants

A policy of single embryo transfer (SET) reduces the risk of perinatal mortality in infants born as a result of IVF and ICSI. The conclusion emerged from an analysis of more than 50,000 births recorded in the Australian and New Zealand Assisted Reproduction Technology Database between 2004 and 2008, where the introduction of an SET policy has been associated with a reduction in overall perinatal mortality for IVF and ICSI babies.

4 Jul 2012

Blog posts address London Summit on Family Planning

The London Summit on Family Planning, co-sponsored by the U.K. government and the Bill & Melinda Gates Foundation with support from UNFPA and other partners, is scheduled to take place next week.

4 Jul 2012

UCAOA year-long campaign to raise national understanding about urgent care centers

On June 28, 2012 the Supreme Court ruled in favor of the Affordable Care Act by a 5-4 vote. This decision will ultimately impact all Americans, but targets the 16.3% of the population that was uninsured last year. That equates to 49.9 million Americans who could be seeking medical care.

4 Jul 2012

Medicaid expansion draws mixed reaction from states

In the wake of the Supreme Court ruling making the law's Medicaid expansion optional, some state officials say they will opt out because they cannot afford even 10 percent of the program's costs. Others, though, are moving forward.

4 Jul 2012

Live zoster vaccine associated with reduced risk of HZ in patients with immune-mediated diseases

Although some have suggested that patients receiving medication for immune-mediated diseases such as rheumatoid arthritis or psoriasis may be at increased risk of herpes zoster (HZ; shingles) shortly after receipt of the vaccine, an analysis that included nearly 20,000 vaccinated Medicare beneficiaries finds that the live zoster vaccine is not associated with an increased risk of HZ shortly after vaccination in patients currently treated with biologics, and that it is associated with a significantly reduced longer-term risk of HZ in patients with an immune-mediated disease, according to a study in the July 4 issue of JAMA.

4 Jul 2012

New round of polls shows Americans are ready to move on

A mix of early poll results shows that, though the Supreme Court's decision didn't quiet the partisan feelings associated with the health law, many people want the battle over the sweeping overhaul to stop. Additionally, the ruling does not appear to have impacted opinions regarding the race for the White House.

4 Jul 2012

The Jeffrey Epstein VI Foundation supports Genetic Initiative at CCFA

The Jeffrey Epstein VI Foundation, which actively supports science research, has given substantial support to the Crohn's and Colitis Foundation of America to continue its Genetic Initiative to find a cure for the diseases.

4 Jul 2012

GlaxoSmithKline agrees to plead guilty, pay $3B settlement

Drugmaker GlaxoSmithKline has agreed to plead guilty to fraud charges and pay $3 billion in total -- with some money going to nearly every state -- for promoting its bestselling antidepressants such as Paxil and Wellbutrin for unapproved uses, failing to report safety data about a top diabetes drug and improperly marketing other drugs.

4 Jul 2012